All In MedTech

Device Trial Radar · NCT06798740

Post Market Registry Study of Intracranial Aneurysms Treated With Sugita Clipping Devices

Last checked: Nov 20, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Apr 14, 2025

Primary completion

Feb 14, 2027

Study completion Feb 14, 2033

Sponsor

Lead sponsor
Mizuho CorporationAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 29, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to verify the performance and safety of the Sugita Aneurysm Clips devices when used as intended and to identify possible risk factors. Data collected will be used to support the continuing performance and safety of the devices in the post-market use environment in Europe. Subjects who have an intracranial aneurysm that the physician intends to treat with the subject devices will be included in the study. Subjects will be followup as per hospital standard of care for 5 years.

Conditions

  • Brain Aneurysm

Interventions

  • Sugita Titanium Aneurysm Clip IIDevice

    Aneurysm clipping is a surgical procedure used to treat brain aneurysms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of permanent aneurysm occlusionsTime frame: Up to 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Universitätsklinikum Essen

    Essen, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.